Ondansetron Injection
Product Images NDC 55154-2877

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-2877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3aafa187 Bacf 4de7 Ba5c 6b9bc41e372c 00

3aafa187 Bacf 4de7 Ba5c 6b9bc41e372c 00
Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) single dose vials label. The label states a package of 5 x 2 mL single dose vials for intravenous or intramuscular injection. It includes storage instructions, usage warnings, manufacturer West-Ward in Eatontown, NJ, and distributor Cardinal Health in Dublin, OH. The label indicates the product is sterile and light sensitive, RX only, and intended for institutional use.*
FDA Label Image

Chemical Structure (Image 02)

Chemical Structure (Image 02)
Chemical structure of Ondansetron, showing its molecular framework including benzene and imidazole rings along with associated functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.